≡ Risteys
R9

Documentation Changelog GitHub Contact & Feedback

Neuroendocrine tumor and carcinoma of stomach (controls excluding all cancers)

PheWeb

C3_STOMACH_NEUROENDOCRINE_EXALLC

No definition available.

Endpoint definition

↥
FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector

Check conditions None

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Cancer registry: Topography ICD-O-3 C16
Cancer registry: Morphology ICD-O-3 8240|824[2-4]|8246|8249
Cancer registry: Behaviour codes 3

1 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector

Include endpoints None

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

111

diagram downward connector
C3_STOMACH_NEUROENDOCRINE_EXALLC

Control definitions

Control exclude C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze DF9

Similar endpoints

↥

List of similar endpoints to Neuroendocrine tumor and carcinoma of stomach (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 111 61 50
Unadjusted prevalence (%) 0.03 0.03 0.03
Mean age at first event (years) 59.52 56.66 63.00

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: C3_STOMACH_NEUROENDOCRINE_EXALLC – Neuroendocrine tumor and carcinoma of stomach (controls excluding all cancers)
GWS hits:

Survival analyses between endpoints

↥

Plot

before Neuroendocrine tumor and carcinoma of stomach (controls excluding all cancers)
after Neuroendocrine tumor and carcinoma of stomach (controls excluding all cancers)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Neuroendocrine tumor and carcinoma of stomach (controls excluding all cancers)

↥

Endpoint not on priority list, no data to show.